We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
2601
Anika Therapeutics
ANIK
$215M
-13,383
Closed -$546K
YDKG
2602
Yueda Digital Holding
YDKG
$5.38M
-325
Closed -$445K
APVO icon
2603
Aptevo Therapeutics
APVO
$4.96M
0
-$244K
ARCO icon
2604
Arcos Dorados Holdings
ARCO
$1.74B
-549,534
Closed -$2.76M
ARE icon
2605
Alexandria Real Estate Equities
ARE
$9.37B
-7,918
Closed -$1.3M
ARLP icon
2606
Alliance Resource Partners
ARLP
$3.34B
-42,572
Closed -$247K
ARMK icon
2607
Aramark
ARMK
$15B
-148,558
Closed -$4.05M
AROC icon
2608
Archrock
AROC
$6.16B
-483,316
Closed -$4.59M
ASH icon
2609
Ashland
ASH
$3.34B
-169,835
Closed -$15.1M
ASIX icon
2610
AdvanSix
ASIX
$542M
-11,453
Closed -$307K
ASML icon
2611
ASML
ASML
$596B
-2,039
Closed -$1.26M
ASX icon
2612
ASE Group
ASX
$68.3B
-377,741
Closed -$2.91M
ATLC icon
2613
Atlanticus Holdings
ATLC
$1.57B
-7,021
Closed -$213K
ATNM icon
2614
Actinium Pharmaceuticals
ATNM
$26.3M
-13,019
Closed -$99K
ATO icon
2615
Atmos Energy
ATO
$29.7B
-121,633
Closed -$12M
ATR icon
2616
AptarGroup
ATR
$8.69B
-6,069
Closed -$860K
ATRA icon
2617
Atara Biotherapeutics
ATRA
$72.6M
-3,051
Closed -$1.1M
AU icon
2618
AngloGold Ashanti
AU
$39.4B
-105,100
Closed -$2.31M
AVAL icon
2619
Grupo Aval
AVAL
$5.82B
-58,054
Closed -$361K
AVNS
2620
DELISTED
Avanos Medical
AVNS
-48,785
Closed -$2.13M
AVXL icon
2621
Anavex Life Sciences
AVXL
$231M
-163,087
Closed -$2.44M
AWI icon
2622
Armstrong World Industries
AWI
$7.37B
-21,007
Closed -$1.89M
AWK icon
2623
American Water Works
AWK
$27B
-143,891
Closed -$21.6M
AWR icon
2624
American States Water
AWR
$3.44B
-21,226
Closed -$1.6M
AXDX
2625
DELISTED
Accelerate Diagnostics
AXDX
-2,713
Closed -$225K

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.